Inactive Instrument
Body and Mind Inc. Stock Other OTC
Stocks
BMMJ
US09689V1008
Pharmaceuticals
OTC Markets Traded| Market Cap | 4.65M 4.15M 3.87M 3.52M 6.62M 448M 6.67M 46.7M 18.17M 229M 17.46M 17.08M 735M | P/E 2022 |
-0.39x | P/E 2023 | -0.52x |
|---|---|---|---|---|---|
| Enterprise Value | 23.03M 20.55M 19.14M 17.42M 32.81M 2.22B 33.05M 231M 90M 1.13B 86.47M 84.61M 3.64B | EV / Sales 2022 |
0.73x | EV / Sales 2023 | 1.33x |
| Free-Float |
86.65% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +4.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mills
CEO | Chief Executive Officer | 57 | 2019-08-20 |
Dong Shim
DFI | Director of Finance/CFO | 43 | 2019-08-21 |
Stephen Hoffman
COO | Chief Operating Officer | 61 | 2018-11-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mills
BRD | Director/Board Member | 57 | 2020-01-22 |
Stephen Hoffman
BRD | Director/Board Member | 61 | 2020-02-29 |
Brent Reuter
BRD | Director/Board Member | 57 | 2019-10-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.43% | +3.36% | - | - | 29.8K | |
| +0.02% | -3.52% | +36.11% | +111.11% | 1,019B | |
| -1.21% | -6.99% | +34.08% | +60.96% | 610B | |
| +1.12% | -0.20% | +13.62% | +80.24% | 470B | |
| -3.30% | -6.15% | +56.45% | +34.69% | 344B | |
| +0.93% | -1.83% | +21.65% | +41.43% | 336B | |
| +0.12% | -4.05% | +10.70% | +33.53% | 266B | |
| -0.89% | -5.83% | -7.00% | +7.91% | 241B | |
| -0.01% | -3.62% | +35.28% | +52.02% | 218B | |
| -0.08% | -4.98% | +28.34% | +93.61% | 179B | |
| Average | +0.64% | -3.63% | +25.47% | +57.28% | 409.2B | |
| Weighted average by Cap. | +0.45% | -3.51% | +28.40% | +68.66% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 31.64M 28.22M 26.3M 23.93M 45.06M 3.05B 45.4M 318M 124M 1.56B 119M 116M 5B | 22.82M 20.36M 18.97M 17.26M 32.5M 2.2B 32.74M 229M 89.16M 1.12B 85.67M 83.82M 3.61B |
| Net income | -28.68M -25.58M -23.83M -21.69M -40.85M -2.76B -41.15M -288M -112M -1.41B -108M -105M -4.53B | -20.78M -18.54M -17.27M -15.72M -29.6M -2B -29.82M -209M -81.2M -1.02B -78.02M -76.34M -3.28B |
| Net Debt | 11.67M 10.41M 9.7M 8.83M 16.62M 1.12B 16.75M 117M 45.6M 574M 43.81M 42.87M 1.84B | 18.38M 16.4M 15.28M 13.9M 26.18M 1.77B 26.38M 185M 71.83M 904M 69.01M 67.52M 2.9B |
Employees
-
Sector
Pharmaceuticals
